56.64
1.35%
0.554
前日終値:
$56.09
開ける:
$56.16
24時間の取引高:
147.12K
Relative Volume:
0.17
時価総額:
$5.88B
収益:
$628.56M
当期純損益:
$141.82M
株価収益率:
69.93
EPS:
0.81
ネットキャッシュフロー:
$142.60M
1週間 パフォーマンス:
+3.76%
1か月 パフォーマンス:
+15.76%
6か月 パフォーマンス:
+97.40%
1年 パフォーマンス:
+123.64%
Corcept Therapeutics Inc Stock (CORT) Company Profile
名前
Corcept Therapeutics Inc
セクター
電話
650.688.8803
住所
101 REDWOOD SHORES PARKWAY, REDWOOD CITY
CORT を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
CORT | 56.51 | 5.88B | 628.56M | 141.82M | 142.60M | 0.81 |
VRTX | 448.57 | 115.74B | 10.63B | -479.80M | -1.35B | 13.33 |
REGN | 746.76 | 81.65B | 13.85B | 4.65B | 3.32B | 35.06 |
ARGX | 592.05 | 34.86B | 1.86B | -40.29M | -1.28B | -4.16 |
ALNY | 249.12 | 32.09B | 2.09B | -332.26M | 16.06M | -4.14 |
BNTX | 103.91 | 24.49B | 3.30B | -501.07M | 1.03B | 11.54 |
Corcept Therapeutics Inc Stock (CORT) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2023-11-06 | アップグレード | Truist | Hold → Buy |
2023-04-11 | 開始されました | SVB Securities | Market Perform |
2023-04-04 | 開始されました | Piper Sandler | Overweight |
2023-02-15 | ダウングレード | Jefferies | Buy → Hold |
2022-08-01 | ダウングレード | Truist | Buy → Hold |
2022-07-27 | アップグレード | Jefferies | Hold → Buy |
2022-06-27 | 再開されました | Canaccord Genuity | Buy |
2022-02-02 | 開始されました | Canaccord Genuity | Buy |
2022-01-28 | 開始されました | Truist | Buy |
2020-08-05 | ダウングレード | Jefferies | Buy → Hold |
2019-09-24 | 開始されました | Jefferies | Buy |
2019-09-06 | 開始されました | H.C. Wainwright | Buy |
2019-02-04 | ダウングレード | B. Riley FBR | Buy → Neutral |
2018-08-10 | 繰り返されました | Stifel | Hold |
2018-05-31 | ダウングレード | Stifel | Buy → Hold |
2018-03-09 | 開始されました | B. Riley FBR, Inc. | Buy |
2017-08-31 | 開始されました | Stifel | Buy |
2017-02-02 | 開始されました | Ladenburg Thalmann | Buy |
2015-04-21 | 開始されました | FBR Capital | Outperform |
2014-01-13 | ダウングレード | Stifel | Buy → Hold |
2013-08-09 | ダウングレード | Janney | Buy → Neutral |
2013-08-09 | ダウングレード | Ladenburg Thalmann | Buy → Neutral |
2012-02-21 | 繰り返されました | JMP Securities | Mkt Outperform |
2010-01-06 | アップグレード | Ladenburg Thalmann | Neutral → Buy |
2008-07-17 | 開始されました | Rodman & Renshaw | Mkt Outperform |
2007-06-21 | アップグレード | Punk, Ziegel & Co | Mkt Perform → Accumulate |
すべてを表示
Corcept Therapeutics Inc (CORT) 最新ニュース
Empowered Funds LLC Makes New Investment in Corcept Therapeutics Incorporated (NASDAQ:CORT) - MarketBeat
Wall Street Analysts Think Corcept (CORT) Could Surge 37.91%: Read This Before Placing a Bet - Yahoo Finance
Corcept Therapeutics Incorporated (NASDAQ:CORT) Shares Acquired by Connor Clark & Lunn Investment Management Ltd. - MarketBeat
Cornercap Investment Counsel Inc. Has $426,000 Stock Holdings in Corcept Therapeutics Incorporated (NASDAQ:CORT) - MarketBeat
Royce & Associates LP Has $16.81 Million Holdings in Corcept Therapeutics Incorporated (NASDAQ:CORT) - MarketBeat
Teva Defends Mifepristone Antitrust Case Against Corcept - Law360
Intellectus Partners LLC Purchases Shares of 54,859 Corcept Therapeutics Incorporated (NASDAQ:CORT) - MarketBeat
Corcept Therapeutics Incorporated (NASDAQ:CORT) Receives $65.25 Average Target Price from Analysts - Defense World
Corcept Therapeutics director Daniel Swisher sells $131,736 in stock By Investing.com - Investing.com Australia
Principal Financial Group Inc. Sells 20,770 Shares of Corcept Therapeutics Incorporated (NASDAQ:CORT) - MarketBeat
Corcept Therapeutics director Daniel Swisher sells $131,736 in stock - Investing.com
Corcept (CORT) Upgraded to Strong Buy: Here's Why - MSN
Cushing's Syndrome Market to Show a Rise During the Study Period | - openPR
Cushing's Syndrome Market Will Drive an Exponential CAGR - openPR
Corcept Therapeutics Incorporated (NASDAQ:CORT) Given Consensus Recommendation of "Buy" by Brokerages - MarketBeat
24,800 Shares in Corcept Therapeutics Incorporated (NASDAQ:CORT) Acquired by Versor Investments LP - MarketBeat
Wealth Enhancement Advisory Services LLC Takes $238,000 Position in Corcept Therapeutics Incorporated (NASDAQ:CORT) - Defense World
Lisanti Capital Growth LLC Increases Stock Holdings in Corcept Therapeutics Incorporated (NASDAQ:CORT) - MarketBeat
Zacks Industry Outlook Madrigal, Corcept, Catalyst Larimar And Theravance - Barchart
Zacks Industry Outlook Madrigal, Corcept, Catalyst Larimar and Theravance - Yahoo Finance
CWA Asset Management Group LLC Acquires Shares of 20,800 Corcept Therapeutics Incorporated (NASDAQ:CORT) - MarketBeat
Robeco Institutional Asset Management B.V. Trims Holdings in Corcept Therapeutics Incorporated (NASDAQ:CORT) - MarketBeat
Corcept Therapeutics Stock Surges 61% in 2024: A Must Buy? - MSN
Corcept Therapeutics (NASDAQ:CORT) Stock Price Up 8.9%Time to Buy? - MarketBeat
US Bancorp DE Purchases 12,177 Shares of Corcept Therapeutics Incorporated (NASDAQ:CORT) - MarketBeat
M&G Plc Buys New Shares in Corcept Therapeutics Incorporated (NASDAQ:CORT) - MarketBeat
Corcept Therapeutics Incorporated (CORT) Soars to 52-Week High, Time to Cash Out? - MSN
New York State Teachers Retirement System Sells 17,222 Shares of Corcept Therapeutics Incorporated (NASDAQ:CORT) - MarketBeat
Corcept Therapeutics' chief development officer sells $489,700 in stock - Investing.com
Corcept Therapeutics' chief development officer sells $489,700 in stock By Investing.com - Investing.com UK
Here is Why Growth Investors Should Buy Corcept (CORT) Now - Yahoo Finance
Corcept Stock At New High; Will The Upcoming Regulatory And Clinical Trial Catalysts Take It Higher? - RTTNews
Roman Butler Fullerton & Co. Has $261,000 Stock Holdings in Corcept Therapeutics Incorporated (NASDAQ:CORT) - MarketBeat
Creative Planning Acquires 841 Shares of Corcept Therapeutics Incorporated (NASDAQ:CORT) - Defense World
Corcept Therapeutics stock soars to all-time high of $50.23 - Investing.com India
Corcept Therapeutics (NASDAQ:CORT) Sets New 1-Year HighWhat's Next? - MarketBeat
Corcept Therapeutics stock soars to all-time high of $50.23 By Investing.com - Investing.com Australia
Wall Street Analysts Believe Corcept (CORT) Could Rally 56.66%: Here's is How to Trade - Yahoo Finance
Recent Price Trend in Corcept (CORT) is Your Friend, Here's Why - Yahoo Canada Finance
What is HC Wainwright’s Forecast for CORT FY2024 Earnings? - Defense World
HC Wainwright Has Bullish Forecast for CORT FY2024 Earnings - MarketBeat
What is HC Wainwright’s Estimate for CORT FY2026 Earnings? - Defense World
Corcept Trumps Q3 Earnings & Sales Estimates, Ups '24 Revenue View - MSN
Corcept Therapeutics (CORT) Stock Declines Amid Market Activity - GuruFocus.com
Earnings Estimates Moving Higher for Corcept (CORT): Time to Buy? - MSN
Corcept Therapeutics (NASDAQ:CORT) Stock Price Down 3.2%Here's What Happened - MarketBeat
FY2026 Earnings Estimate for CORT Issued By HC Wainwright - MarketBeat
Corcept Therapeutics Incorporated (NASDAQ:CORT) Q3 2024 Earnings Call Transcript - Insider Monkey
Corcept’s relacorilant GRADIENT trial misses primary endpoint - Yahoo Finance
Corcept Therapeutics Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
Earnings call: Corcept Therapeutics reports robust Q3 growth, raises guidance - Investing.com Canada
Corcept Therapeutics Inc (CORT) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):